PRELIMINARY TOPICS

• Translating science into medicine

• Capital Market Outlook

• Assessing investment risk

• Redefining care of chronic prevalent retinal diseases: new therapeutic advances

• New therapeutic advances in Inherited Retinal diseases

• Emerging treatments for dry AMD: what to expect in the near future?

• Next generation revolution: spotlight on latest innovation in retinal diseases

• Accelerating drug development: the future of clinical trial development and study design for retina clinical programs

• Supporting research at the intersection of regulatory policy & science: on what truisms can we rely?

• Ophthalmology investment outlook

• EYENOVATE DOLPHIN TANK